Investigating methotrexate toxicity within a randomized double-blinded, placebo-controlled trial: Rationale and design of the Cardiovascular Inflammation Reduction Trial-Adverse Events (CIRT-AE) Study
Sparks JA, Barbhaiya M, Karlson EW et al. Keywords:
Genetics; Methotrexate; Pharmacovigilance; Polyglutamate; Toxicity